Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
|
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [42] A bacterial model system for understanding multi-drug resistance
    Saier, MH
    Paulsen, IT
    Matin, A
    MICROBIAL DRUG RESISTANCE, 1997, 3 (04) : 289 - 295
  • [43] Recent trend of multi-drug resistance in Pseudomonas aeruginosa
    Khan, S.
    Singh, P.
    Rashmi
    Asthana, A.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2014, 13 (04): : 438 - 442
  • [44] Trends and challenges of multi-drug resistance in childhood tuberculosis
    Zhuang, Zengfang
    Sun, Lin
    Song, Xiaorui
    Zhu, Hanzhao
    Li, Lianju
    Zhou, Xintong
    Mi, Kaixia
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [45] Antimalarial multi-drug resistance in Asia: Mechanisms and assessment
    Uhlemann, AC
    Krishna, S
    MALARIA: DRUGS, DISEASE AND POST-GENOMIC BIOLOGY, 2005, 295 : 39 - 53
  • [46] Formulation strategy to overcome multi-drug resistance (MDR)
    Cheong-Weon Cho
    Archives of Pharmacal Research, 2011, 34 : 511 - 513
  • [47] Small Molecular Weapons against Multi-Drug Resistance
    Looper, Ryan E.
    Boger, Dale L.
    Silver, Lynn L.
    ACCOUNTS OF CHEMICAL RESEARCH, 2021, 54 (13) : 2785 - 2787
  • [48] Biofilms preserve the transmissibility of a multi-drug resistance plasmid
    Genevieve A. Metzger
    Benjamin J. Ridenhour
    Michael France
    Karol Gliniewicz
    Jack Millstein
    Matthew L. Settles
    Larry J. Forney
    Thibault Stalder
    Eva M. Top
    npj Biofilms and Microbiomes, 8
  • [49] THE EFFECT OF GENETIC VARIATION ON MULTI-DRUG RESISTANCE PROTEIN 4 EXPRESSION
    Martin, Michael A.
    Garcia, Adriana A.
    Kroetz, Deanna L.
    DRUG METABOLISM REVIEWS, 2015, 47 : 279 - 279
  • [50] Multi-drug resistance Trichophyton indotineae in a stray dog
    Oladzad, Vahid
    Omran, Ayatollah Nasrollahi
    Haghani, Iman
    Nabili, Mojtaba
    Seyedmousavi, Seyedmojtaba
    Hedayati, Mohammad Taghi
    RESEARCH IN VETERINARY SCIENCE, 2024, 166